Pharmaceutical company Abbott Laboratories has filed a lawsuit against ACT-UP Paris for what an Abbott representative called an “unlawful organization of a cyber attack” on the pharmaceutical company’s website last April. As a measure of protest against Abbott’s high drug prices, ACTUP Paris allegedly posted details on its site encouraging people to use a software tool to repeatedly access—and then crash—Abbott’s website.